Axon Stock Falls as Federal Drone Deployments Stall

What happened

Axon fell 10.11% in premarket after third-quarter revenue of $908.6 million and non-GAAP earnings per share of $1.72 missed analyst estimates. It lowered its full-year growth outlook to about 30%, excluding three federal Dedrone deployments worth about $130 million, and cut its free cash flow target to $350 million to $400 million.

Confirmed

Global impact / market context

The delayed federal deployments reduce expected connected-device sales and help explain why Axon lowered its growth outlook. An accelerated inventory build also ties up cash, contributing to a lower free cash flow target; that leaves less cash available for other spending unless sales or inventory timing improves.

Analyst inference

Results were mixed: software and services revenue grew 43%, while connected devices revenue rose 16% and adjusted gross margin fell to 59.2%. The margin measure shows profit after direct costs; Axon attributed the decline to product mix, memory costs and newer product categories.

Confirmed

What to watch

1. Whether the three federal Dedrone deployments worth about $130 million are completed this year matters for revenue timing; Axon said it cannot be sure they will come through. Confirmed
2. Compare fourth-quarter revenue with Axon's $990 million to $1.01 billion forecast; a shortfall could add pressure to its roughly 30% full-year growth outlook. Proposed
3. Watch inventory levels and free cash flow against the $350 million to $400 million target, since a slower inventory build could release cash while delays could keep it tied up. Analyst inference

Evidence

• gurufocus.com